维普中文期刊产品整合服务
52篇 您的检索式:作者名="Sanders Mark"
    题名 作者 年代 出处 被引量
1Towards Quantitatively Understanding the Complexity of Social-Ecological Systems——From Connection to Consilience显示文摘The complexity of social-ecological systems(SES) is rooted in the outcomes of node activities connected by network topology. Thus far, in network dynamics research, the connectivity degree(CND), indicating how many nodes are connected to a given node, has been the dominant concept. However, connectivity focuses only on network topology, neglecting the crucial relation to node activities, and thereby leaving system outcomes largely unexplained. Inspired by the phenomenon of ‘‘consensus of wills and coordination of activities' ' often observed in disaster risk management, we propose a new concept of network characteristic, the consilience degree(CSD),aiming to measure the way in which network topology and node activities together contribute to system outcomes. The CSD captures the fact that nodes may assume different states that make their activities more or less compatible.Connecting two nodes with in/compatible states will lead to outcomes that are un/desirable from the perspective of the SES in question. We mathematically prove that the CSD is a generalized CND, and the CND is a special case of CSD. As a general, fundamental concept, the CSD can facilitate the development of a new framework of network properties, models, and theories that allows us to understand patterns of network behavior that cannot be explained in terms of connectivity alone. We further demonstrate that a co-evolutionary mechanism can naturally improve the CSD. Given the generality of co-evolution in SES, we argue that the CSD is an inherent attribute rather than an artificial concept, which underpins the fundamental importance of the CSD to the study of SES.Xiao-Bing Hu Peijun Shi Ming Wang Tao Ye Mark S.Leeson Sander E.van der Leeuw Jianguo Wu Ortwin Renn Carlo Jaeger 2017International Journal of Disaster Risk Science2017,8,4:4
2Gastric sarcoidosis mimicking irritable bowel syndrome-Cause not association?显示文摘肉状瘤是可以在身体影响任何机关的未知原因论的系统病。胃肠道仅仅很少然而在肝外面被影响。症状可能是非特定的。急躁的肠症候群(IBS ) 是普通诊断。IBS 的识别被罗马 II 标准的使用帮助 - 当器质性病不在时。我们与胃的肉状瘤描述一个病人的第一个盒子与 IBS 介绍了症状,但是随后对抑制免疫力的治疗作出回应。John Samuel Leeds Mark Edward McAlindon Eleanor Lorenz Asha Kumari Dube David Surendran Sanders 2006World Journal of Gastroenterology2006,12,29:3
3Efficient isolation of major procyanidin A-type dimers from peanut skins and B- type dimers from grape seeds 显示文摘Appeldoorn Maaike M Sanders Mark Vincken Jean- Paul et a/ 2009Food Chemistry2009,117,4:1
4Primary periosteal lymphoma: an unusual presentation of non-Hodgkin’s lymphoma with radiographic, MR imaging, and pathologic correlation显示文摘Scot E. Campbell Timothy W. Filzen Shane M. Bezzant Douglas P. Beall Mark P. Burton Timothy G. Sanders Theodore W. Parsons 2003Skeletal Radiology2003,,4:1
5Prediction of human microR- NA targets 显示文摘John B Sander C Marks DS 2006Methods Mol Biol2006,342,:1
6Theory of mind-based action in children form the autism spectrum显示文摘Sander B Carolien R Mark MT et a1 2003J Autism Dev Disord2003,33,5:1
7mRNA turnover rate limits siRNA and microRNA efficacy显示文摘Larsson E Sander C Marks D 2010Mol Syst Biol2010,6,:1
8STEM,STEM Education,STEM mania显示文摘Mark Sanders 2009The Technology Teacher2009,68,4:1
9Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease显示文摘Stephen M. Barratt John S. Leeds Kerry Robinson Premal J. Shah Alan J. Lobo Mark E. McAlindon David S. Sanders 2011European Journal of Gastroenterology & Hepatology2011,,:1
10A real time RT-PCR assay for the specific detection of Peste des petits ruminants virus显示文摘Carrie A. Batten Ashley C. Banyard Donald P. King Mark R. Henstock Lorraine Edwards Anna Sanders Hubert Buczkowski Chris C.L. Oura Tom Barrett 2010Journal of Virological Methods2010,,2:1
11Evaluating the role of small-bowel endoscopy in clinical practice: the largest single-centre experience显示文摘Reena Sidhu Mark E. McAlindon Kaye Drew Suzanne Hardcastle Iain C. Cameron David S. Sanders 2012European Journal of Gastroenterology & Hepatology2012,,5:1
12Disentangling the drivers of β diversity along latitudinal and elevational gradients 显示文摘Kraft NJB Comita LS Chase JM Sanders NJ Swenson NG Crist TO Stegen JC Mark V Brad B Anderson MJ 2011Science2011,333,6050:1
13Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments.Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis 2022Stroke & Vascular Neurology2022,7,2:1
14Prediction of human microRNA targets显示文摘JOHN B SANDER C MARKS D S 2006Methods in Molecular Biology (Clifton NJ)2006,342,1:1
15Prediction of human microRNA targets显示文摘John B Sander C Marks DS 2006Methods Mol Biol2006,342,:1
16Relation between pO 2 , 31 P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy显示文摘Mark W. Dewhirst Jean M. Poulson Daohai Yu Linda Sanders Micha?l Lora-Michiels Zeljko Vujaskovic Ellen L. Jones Thaddeus V. Samulski Barbara E. Powers David M. Brizel Leonard R. Prosnitz H. Cecil Charles 2005International Journal of Radiation Oncology Biology Physics2005,,2:1
17miR-122,a mammalian liver-specific microRNA,is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1显示文摘Chang J Nicolas E Marks D Sander C Lerro A Buendia MA 2004RNA Biol2004,1,2:1
18Prediction of human microRNA targets 显示文摘John B Sander C Marks DS 2006Methods Mol Biol2006,342,:1
19miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1 显示文摘Chang J Nicolas E Marks D Sander C Lerro A Buendia MA 2004RNA Biol2004,1,2:1
20Identification of virus-encoded microRNAs 显示文摘Pfeffer S Zavolan M Grasser FA Chien M Russo JJ Ju J John B Enright AJ Marks D Sander C Tuschl T 2004Science2004,304,5671:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费